[Radiotherapy and cardiovascular toxicity].

Recenti Prog Med

UOC Medicina Cardiovascolare e RM Lab, Fondazione G. Monasterio CNR-Regione Toscana, Pisa.

Published: June 2009

The authors describe the case of a 41-year old patient, with multiple cardiovascular risk factors and past radiotherapic treatment at the chest and cervical region which developed a waste coronary and carotid atherosclerosis associated with aortic and mitralic valvular disease. The role of radiotherapy in developing cardiovascular diseases, in particular about valvular disease is discussed.

Download full-text PDF

Source

Publication Analysis

Top Keywords

valvular disease
8
[radiotherapy cardiovascular
4
cardiovascular toxicity]
4
toxicity] authors
4
authors describe
4
describe case
4
case 41-year
4
41-year patient
4
patient multiple
4
multiple cardiovascular
4

Similar Publications

Characterization of LTBP2 mutation causing mitral valve prolapse.

Eur Heart J Open

January 2025

Department of Medicine, Cardiovascular Precision Medicine Center, Hadassah Hebrew University Medical Center, P.O. Box 12000, 9112001 Jerusalem, Israel.

Aims: Mitral valve prolapse (MVP) is a common valvular disorder associated with significant morbidity and mortality, with a strong genetic basis. This study aimed to identify a mutation in a family with MVP and to characterize the valve phenotype in LTBP2 knockout (KO) mice.

Methods And Results: Exome sequencing and segregation analysis were performed on a large family with MVP.

View Article and Find Full Text PDF

Introduction: The severity of mitral stenosis (MS) is commonly assessed using mitral valve area (MVA) measured with transthoracic echocardiography (TTE). The dimensionless index (DI) of mitral valve (MV) was recently studied in degenerative MS. We evaluated DI MV in rheumatic MS and studied its relationship with clinical outcomes.

View Article and Find Full Text PDF

Infectious intracranial aneurysms (IIAs) are rare lesions with fragile arterial walls located within the aneurysms, carrying a high risk of rupture. Standard management often involves antibiotic therapy and parent artery occlusion; however, the latter carries a significant risk of cerebral infarction. This report presents a case of an unruptured IIA following cerebral infarction, successfully treated with coil embolization while preserving the parent artery.

View Article and Find Full Text PDF

Introduction: Heart failure with preserved ejection fraction (HFpEF) is characterised by severe exercise intolerance, particularly in those living with obesity. Low-energy meal-replacement plans (MRPs) have shown significant weight loss and potential cardiac remodelling benefits. This pragmatic randomised trial aims to evaluate the efficacy of MRP-directed weight loss on exercise intolerance, symptoms, quality of life and cardiovascular remodelling in a multiethnic cohort with obesity and HFpEF.

View Article and Find Full Text PDF

Mitral Valve Prolapse Caused by TLL1 Gain-of-Function Mutation.

Can J Cardiol

January 2025

The Morris Kahn Laboratory of Human Genetics, Faculty of Health Sciences and National Institute of Biotechnology in the Negev, Ben Gurion University of the Negev, Be'er Sheva, Israel; Genetics Institute, Soroka University Medical Center, Be'er Sheva, Israel; The Danek Gertner Institute of Human Genetics, Sheba Medical Center, Ramat Gan, Israel. Electronic address:

Background: Mitral valve prolapse (MVP) is a common cardiac valvular anomaly that can be caused by mutations in genes of various biological pathways. Individuals of three generations of a kindred presented with apparently dominant heredity of isolated MVP.

Methods: Clinical evaluation and echocardiography for all complying family members (n=13).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!